Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathies

Immunology

Volumn 128, Issue 1 PART 2, 2009, Pages

  Kondo, Masahiro ^a   Murakawa, Yohko ^a   Harashima, Nanae ^a   Kobayashi, Shotai ^b   Yamaguchi, Shuhei ^a   Harada, Mamoru ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Dendritic cells; Fas; Inflammatory myopathy; Interleukin 23; T helper 17

Indexed keywords

ACEBUTOLOL; CASPASE 3; CASPASE 8; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 12P35; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 23P19; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOMYOSITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATION; POLYMYOSITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASE 8; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; DENDRITIC CELLS; FAS LIGAND PROTEIN; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; MUSCLE CELLS; MYOSITIS; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68249146074     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.03039.x     Document Type: Article

References (41)

1. Figarella-Branger D, Civatte M, Bartoli C, Pellissier JF. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve 2003 28 : 659 82.
2. + T cells cause muscle cell injury directly in polymyositis. Arthritis Rheum 1999 42 : 291 8.
3. Behrens L, Bender A, Johnson MA, Hohlfeld R. Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibers and inflammatory cells. Brain 1997 120 : 929 38.
4. Schneider C, Gold R, Dalakas MC, Schmied M, Lassmann H, Toyka KV, Hartng HP. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. J Neuropathol Exp Neurol 1996 55 : 1205 9.
5. De Bleecker JL, Meire VI, Van Walleghem IE, Groessens IM, Schröder JM. Immunolocalization of FAS and FAS ligand in inflammatory myopthies. Acta Neuropathol 2001 101 : 572 8.
6. Inukai A, Kobayashi Y, Ito K, Doyu M, Takano A, Honda H, Sobue G. Expression of Fas antigen is not associated with apoptosis in human myopathies. Muscle Nerve 1997 20 : 702 9.
7. Nagaraju K, Cascila-Rosen L, Rosen A et al. The inhibition of apoptosis in myositis and in normal muscle cells. J Immunol 2000 164 : 5459 65.
8. Christopher-Stine L, Plotz PH. Myositis: an update on pathogenesis. Curr Opin Rheumatol 2004 16 : 700 6.
9. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992 148 : 1274 9.
10. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995 270 : 1189 92.
11. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the Fas ligand in T cell lineage. J Immunol 1995 154 : 3806 13.
12. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P. TCR/CD3 coupling to Fas based cytotoicity. J Exp Med 1995 181 : 781 6.
13. Chervonsky AV, Wang Y, Wong FS, Flavell RA, Janeway CA Jr., Martis LA. The role of Fas in autoimmune diabetes. Cell 1997 89 : 17 24.
14. Walender H, Sobel RA, Howard E, Kuchroo VK. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol 1997 159 : 3100 3.
15. Kidoya H, Umemura M, Kawabem T, Matsuzaki G, Yahaagi A, Imamura R, Suda T. Fas ligand induces cell-autonomous IL-23 production in dendritic cells, a mechanism for fas ligand-induced IL-17 production. J Immunol 2005 175 : 8024 31.
16. Rescigno M, Piguet V, Valzasina B et al. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1β, and the production of interferon β in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J Exp Med 2000 192 : 1661 8.
17. Leipidi H, Frances V, Figarella-Branger D, Bartoli C, Machado-Baeta A, Pellissier JF. Local expression of cytokines in idiopathic inflammatory myopathies. Neuropathol Appl Neurobiol 1998 24 : 73 9.
18. Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997 40 : 865 74.
19. Lundberg IE, Nyberg P. New developments in the role of cytokines and chemokines in inflammatory myopathies. Curr Opin Rheumatol 1998 10 : 521 9.
20. Tews DS, Goebel HH. Cytokine expression profile in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol 1996 55 : 342 7.
21. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006 116 : 1218 22.
22. Bettelli E, Oukka M, Kuchroo V. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007 8 : 345 50.
23. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975 20 : 403 7.
24. Ashany D, Savir A, hardwaji N, Elkon KB. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. J Immunol 1999 163 : 5303 11.
25. Oppmann B, Lesley R, Blom B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000 13 : 715 27.
26. Yamada H, Nakagawa M, Higuchi I, Hkubo R, Osame M. Type II muscle fibers are stained by anti-Fas antibody. J Neurol Sci 1995 134 : 115 8.
27. Li M, Dalakas MC. Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies. J Neuroimmunol 2000 106 : 1 5.
28. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A. Anti-Fas/Apo-1 antibody mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 1994 94 : 954 64.
29. Keane MM, Ettenberg SA, Lowrey GA, Russell EK, Lipkowitz S. Fas expression and function in normal and malignant breast cell lines. Cancer Res 1996 56 : 4791 8.
30. Müller M, Strand S, Hug H, Heinemann EM, Walczak H. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 1997 99 : 403 13.
31. Matsue H, Kobayashi H, Hosokawa T, Akitaya T, Ohkawara A. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes. Arch Dermatol Res 1995 287 : 315 20.
32. Page G, Chevrel G, Miossec P. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis. Arthritis Rheum 2004 50 : 199 208.
33. Caproni M, Torchia D, Cardinali C, Volpi W, Del Bianco E, D'Agata A, Fabbri P. Infiltrating cell, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis. Br J Dermatol 2004 151 : 784 91.
34. Annunziato F, Cosmi L, Santarlasci V et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007 204 : 1849 61.
35. Hohlfeld R, Engel AG. The immunobiology of muscle. Immunol Today 1994 15 : 269 74.
36. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986 314 : 329 34.
37. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW. NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995 122 : 715 24.
38. Itoh N, Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 1993 268 : 10932 7.
39. Tewari M, Dixit VM. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 1995 270 : 3255 60.
40. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995 81 : 505 12.
41. Krajewska M, Wang HG, Krajewski S, Zapata JM, Shabaik A, Gascoyne R, Reed JC. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase 3), a cell death protease. Cancer Res 1997 57 : 1605 13.